Skip to main content
Phase III Trials With Docetaxel-Based Combinations for Metastatic Castration-Resistant Prostate Cancer: Time to Learn From Past Experiences
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account?
Sign in
